CUSIP: 03828A101
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
143,223,667
-
Total 13F shares
-
31,465,661
-
Share change
-
+12,189,098
-
Total reported value
-
$40,275,555
-
Put/Call ratio
-
0.01%
-
Price per share
-
$1.28
-
Number of holders
-
38
-
Value change
-
+$15,796,729
-
Number of buys
-
20
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 03828A101?
CUSIP 03828A101 identifies APLT - Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 03828A101:
Institutional Holders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) as of Q2 2023
As of 30 Jun 2023,
Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,465,661 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VR Adviser, LLC, Alyeska Investment Group, L.P., Knoll Capital Management, LLC, FMR LLC, Simplify Asset Management Inc., VANGUARD GROUP INC, Rock Springs Capital Management LP, Point72 Asset Management, L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.